| scholarly article | Q13442814 |
| P50 | author | Myung-Shik Lee | Q63375647 |
| Inhee Mook-Jung | Q91432207 | ||
| P2093 | author name string | Heesun Choi | |
| Moon-Yong Cha | |||
| Seokjo Kang | |||
| Hyunjung Choi | |||
| Sung Min Son | |||
| Sun Ah Park | |||
| P2860 | cites work | Phospholipid scramblase 1 is secreted by a lipid raft-dependent pathway and interacts with the extracellular matrix protein 1 in the dermal epidermal junction zone of human skin | Q24300930 |
| Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction | Q24303900 | ||
| Identification of SNAREs involved in synaptotagmin VII-regulated lysosomal exocytosis | Q24313333 | ||
| Autophagy, Immunity, and Microbial Adaptations | Q27489075 | ||
| Rab proteins as membrane organizers | Q27860861 | ||
| Autophagy fights disease through cellular self-digestion | Q27860902 | ||
| Unconventional secretion of Acb1 is mediated by autophagosomes. | Q27934275 | ||
| Insulin degradation: progress and potential | Q28287093 | ||
| Statins Promote the Degradation of Extracellular Amyloid β-Peptide by Microglia via Stimulation of Exosome-associated Insulin-degrading Enzyme (IDE) Secretion | Q28294279 | ||
| Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations | Q28506710 | ||
| Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme | Q28582802 | ||
| Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β | Q29030555 | ||
| Autophagy: from phenomenology to molecular understanding in less than a decade | Q29614174 | ||
| The role of autophagy in neurodegenerative disease | Q29614834 | ||
| Autophagy in mammalian development and differentiation | Q29615612 | ||
| Decreased clearance of CNS beta-amyloid in Alzheimer's disease | Q29616534 | ||
| Ceramide triggers budding of exosome vesicles into multivesicular endosomes | Q29616811 | ||
| Membrane fusion | Q29618140 | ||
| Molecular mechanisms of ATP secretion during immunogenic cell death | Q30408773 | ||
| MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway. | Q30479122 | ||
| Autophagy regulates endothelial cell processing, maturation and secretion of von Willebrand factor | Q30550240 | ||
| Reduced IRE1α mediates apoptotic cell death by disrupting calcium homeostasis via the InsP3 receptor. | Q30577176 | ||
| Insulin degrading enzyme is expressed in the human cerebrovascular endothelium and in cultured human cerebrovascular endothelial cells | Q33208160 | ||
| Unconventional secretion of Pichia pastoris Acb1 is dependent on GRASP protein, peroxisomal functions, and autophagosome formation. | Q33689637 | ||
| Enhancing astrocytic lysosome biogenesis facilitates Aβ clearance and attenuates amyloid plaque pathogenesis | Q33906596 | ||
| Isoprenoids, small GTPases and Alzheimer's disease | Q33915441 | ||
| Cerebrospinal fluid and plasma biomarkers in Alzheimer disease | Q34098866 | ||
| Signals from the lysosome: a control centre for cellular clearance and energy metabolism | Q34340780 | ||
| Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits | Q34438646 | ||
| Mechanisms of regulated unconventional protein secretion | Q34915147 | ||
| CR6-interacting factor 1 is a key regulator in Aβ-induced mitochondrial disruption and pathogenesis of Alzheimer's disease | Q35579286 | ||
| Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease | Q35698618 | ||
| Deciphering the molecular basis of memory failure in Alzheimer's disease | Q35902501 | ||
| Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases | Q35934211 | ||
| Targeting amyloid-degrading enzymes as therapeutic strategies in neurodegeneration | Q36024893 | ||
| Autophagy: an emerging immunological paradigm | Q36057716 | ||
| Altered APP processing in insulin-resistant conditions is mediated by autophagosome accumulation via the inhibition of mammalian target of rapamycin pathway | Q36410706 | ||
| Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies | Q36526315 | ||
| Non-autophagic roles of autophagy-related proteins | Q36594175 | ||
| Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein | Q36653589 | ||
| Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion. | Q36739965 | ||
| ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions | Q36835522 | ||
| Autophagy, amyloidogenesis and Alzheimer disease | Q37011121 | ||
| Secretory versus degradative autophagy: unconventional secretion of inflammatory mediators | Q37046163 | ||
| Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease | Q37178375 | ||
| Statins inhibit protein lipidation and induce the unfolded protein response in the non-sterol producing nematode Caenorhabditis elegans | Q37385784 | ||
| Regulation of synaptic connectivity by glia | Q37808619 | ||
| Control of autophagy as a therapy for neurodegenerative disease | Q37970303 | ||
| Autophagy intersections with conventional and unconventional secretion in tissue development, remodeling and inflammation | Q38017030 | ||
| Ghrelin Ameliorates Cognitive Dysfunction and Neurodegeneration in Intrahippocampal Amyloid-β1-42 Oligomer-Injected Mice | Q38480879 | ||
| BRI2 protein regulates β-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE). | Q38795575 | ||
| Astrocyte-originated ATP protects Aβ(1-42)-induced impairment of synaptic plasticity. | Q39387852 | ||
| Aβ-induced formation of autophagosomes is mediated by RAGE-CaMKKβ-AMPK signaling | Q39448927 | ||
| Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and non-neural cells | Q41121149 | ||
| Functional relevance of a novel SlyX motif in non-conventional secretion of insulin-degrading enzyme | Q41788885 | ||
| A technique for serial collection of cerebrospinal fluid from the cisterna magna in mouse | Q42584977 | ||
| β-amyloid inhibits protein prenylation and induces cholesterol sequestration by impairing SREBP-2 cleavage. | Q43846570 | ||
| Aβ secretion and plaque formation depend on autophagy | Q44061458 | ||
| Lysosomes are the major vesicular compartment undergoing Ca2+-regulated exocytosis from cortical astrocytes | Q46466539 | ||
| Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. | Q48404445 | ||
| TI-VAMP/VAMP7 is the SNARE of secretory lysosomes contributing to ATP secretion from astrocytes. | Q48763154 | ||
| Systemic autophagy insufficiency compromises adaptation to metabolic stress and facilitates progression from obesity to diabetes | Q59516123 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| autophagy | Q288322 | ||
| astrocyte | Q502961 | ||
| P304 | page(s) | 784-800 | |
| P577 | publication date | 2016-03-10 | |
| P1433 | published in | Autophagy | Q1255295 |
| P1476 | title | Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease | |
| P478 | volume | 12 |
| Q58772504 | 6-Hydroxydopamine induces secretion of PARK7/DJ-1 via autophagy-based unconventional secretory pathway |
| Q47971481 | A diacidic motif determines unconventional secretion of wild-type and ALS-linked mutant SOD1. |
| Q51734741 | Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function. |
| Q55353865 | Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits. |
| Q39139268 | Astrocytic Pathological Calcium Homeostasis and Impaired Vesicle Trafficking in Neurodegeneration |
| Q90473594 | Astroglia in Alzheimer's Disease |
| Q38954394 | Astroglial Vesicular Trafficking in Neurodegenerative Diseases |
| Q38158310 | Astroglial vesicular network: evolutionary trends, physiology and pathophysiology |
| Q39038974 | Autophagy and the endo/exosomal pathways in health and disease |
| Q47301146 | Autophagy's secret life: secretion instead of degradation |
| Q92508479 | Autophagy-dependent secretion: mechanism, factors secreted, and disease implications |
| Q98384539 | Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease |
| Q61808748 | Geniposide-mediated protection against amyloid deposition and behavioral impairment correlates with downregulation of mTOR signaling and enhanced autophagy in a mouse model of Alzheimer's disease |
| Q55289589 | Innate immune activation in Alzheimer’s disease. |
| Q49199697 | Insulin-degrading enzyme is not secreted from cultured cells |
| Q47216965 | Iridoids and Other Monoterpenes in the Alzheimer's Brain: Recent Development and Future Prospects |
| Q96609269 | Leucine regulates autophagy via acetylation of the mTORC1 component raptor |
| Q92875471 | Mechanisms and Pathophysiological Roles of the ATG8 Conjugation Machinery |
| Q37569276 | Metabolic relationship between diabetes and Alzheimer's Disease affected by Cyclo(His-Pro) plus zinc treatment |
| Q50932512 | Multiple functions of insulin-degrading enzyme: a metabolic crosslight? |
| Q45303020 | Neuroglia: Functional Paralysis and Reactivity in Alzheimer's Disease and Other Neurodegenerative Pathologies |
| Q51065764 | Oleocanthal ameliorates amyloid-β oligomers' toxicity on astrocytes and neuronal cells: In vitro studies. |
| Q92384162 | Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress |
| Q91710367 | Pharmacotherapy of Alzheimer's Disease: Seeking Clarity in a Time of Uncertainty |
| Q41582488 | Physical activity and beta-amyloid pathology in Alzheimer's disease: A sound mind in a sound body |
| Q98161909 | Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus |
| Q52629816 | Role of autophagy in IL-1β export and release from cells. |
| Q89406922 | Specific autophagy and ESCRT components participate in the unconventional secretion of CFTR |
| Q51172931 | The Parkinson's disease-linked protein TMEM230 is required for Rab8a-mediated secretory vesicle trafficking and retromer trafficking. |
| Q42353908 | Therapeutic implication of autophagy in neurodegenerative diseases. |
| Q89003185 | Tumor cell-released autophagosomes (TRAP) enhance apoptosis and immunosuppressive functions of neutrophils |
| Q91836044 | Tumor-released autophagosomes induces CD4+ T cell-mediated immunosuppression via a TLR2-IL-6 cascade |
| Q55515366 | Unconventional Secretion and Intercellular Transfer of Mutant Huntingtin. |
| Q40071037 | Using Microscopy Tools to Visualize Autophagosomal Structures in Plant Cells. |
Search more.